Literature DB >> 3291131

Clinical uses of intravenous immunoglobulins.

S A Berkman1, M L Lee, R P Gale.   

Abstract

Immunoglobulins are an important component of host defense against infections. They also play a central role in immune regulation. A wide spectrum of human diseases is associated with decreased or abnormal regulation of immunoglobulin levels. Recently IV preparations of immunoglobulin have become available for clinical studies. There are already substantial data indicating a useful role for IV immunoglobulin in patients with primary hypogammaglobulinemia, neonates predisposed to group B streptococcal infections, individuals with ITP, children with Kawasaki disease, and bone marrow transplant patients predisposed to CMV infections. Promising data have been reported in burn patients and in individuals with CLL; these data require confirmation. Potential areas for future investigation include AIDS, autoimmune disorders, and viral disorders other than CMV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291131

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  11 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

3.  Requirements for safety and quality of intravenous immunoglobulin G preparations.

Authors:  G H Rütter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

4.  Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice.

Authors:  I Krause; M Blank; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 5.  Pure red cell aplasia: review of treatment and proposal for a treatment strategy.

Authors:  A Raghavachar
Journal:  Blut       Date:  1990 Aug-Sep

6.  Natural human IgG inhibits the production of tumor necrosis factor-alpha and interleukin-1 alpha through the Fc portion.

Authors:  A Horiuchi; Y Abe; M Miyake; Y Osuka; S Kimura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.

Authors:  L Krishnamurti; V D Charan; N Desai; H Pati; V P Choudhry
Journal:  Indian J Pediatr       Date:  1994 Mar-Apr       Impact factor: 1.967

8.  Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.

Authors:  A Achiron; R Margalit; R Hershkoviz; D Markovits; T Reshef; E Melamed; I R Cohen; O Lider
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

Review 9.  Brief report: immune factors in autism: a critical review.

Authors:  Ilan Krause; Xiao-Song He; M Eric Gershwin; Yehuda Shoenfeld
Journal:  J Autism Dev Disord       Date:  2002-08

10.  Source of fiber influences growth, immune responses, gut barrier function and microbiota in weaned piglets fed antibiotic-free diets.

Authors:  Qinghui Shang; Hansuo Liu; Di Wu; Shad Mahfuz; Xiangshu Piao
Journal:  Anim Nutr       Date:  2021-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.